These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 8350783)
1. Cholesterol reduction therapy: a double-edged knife. Ong HT Med J Malaysia; 1993 Jun; 48(2):107-12. PubMed ID: 8350783 [TBL] [Abstract][Full Text] [Related]
2. Prevention of coronary heart disease through cholesterol reduction. Grundy SM Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652 [TBL] [Abstract][Full Text] [Related]
3. [Current developments in prevention of coronary heart disease]. Windler E Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967 [TBL] [Abstract][Full Text] [Related]
4. [New results in the management of hypercholesterolemia]. Sármán B Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867 [TBL] [Abstract][Full Text] [Related]
5. [Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO]. Simoons ML; Casparie AF Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2096-101. PubMed ID: 9856223 [TBL] [Abstract][Full Text] [Related]
6. [The role of cholesterol-lowering drugs in prevention of coronary heart disease]. Skałuba Z; Undas R Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease. Marchioli R; Marfisi RM; Carinci F; Tognoni G Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010 [TBL] [Abstract][Full Text] [Related]
8. [Why the cardiologists should be interested in lipids?]. López-Sendón JL; Rubio R; López de Sá E; Delcán JL Rev Esp Cardiol; 1995; 48 Suppl 2():23-32. PubMed ID: 7569272 [TBL] [Abstract][Full Text] [Related]
9. Low density lipoprotein cholesterol: is lower better? Leiter LA Can J Cardiol; 2000 Jan; 16 Suppl A():20A-2A. PubMed ID: 10653927 [TBL] [Abstract][Full Text] [Related]
10. The benefit of cholesterol-lowering medications after coronary revascularization: a population study. Brophy JM; Brassard P; Bourgault C Am Heart J; 2005 Aug; 150(2):282-6. PubMed ID: 16086931 [TBL] [Abstract][Full Text] [Related]
11. Critical appraisal of revised cholesterol guidelines for the very high-risk patient. Rosenson R; Lloyd-Jones D; Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256 [TBL] [Abstract][Full Text] [Related]
12. [Statins in primary prevention of coronary heart disease]. Paulweber B Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004 [TBL] [Abstract][Full Text] [Related]
13. [Is there a relationship between cholesterol reduction, low levels of cholesterol and mortality?]. LaRosa JC Rev Esp Cardiol; 1995; 48 Suppl 2():14-7. PubMed ID: 7569270 [TBL] [Abstract][Full Text] [Related]
14. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women. Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213 [TBL] [Abstract][Full Text] [Related]
15. Hypercholesterolemia: a reversible risk factor for coronary heart disease. Mishkel MA CMAJ; 1989 Feb; 140(4):419. PubMed ID: 2644008 [No Abstract] [Full Text] [Related]
16. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents]. De Caterina R; Lenzi S G Ital Cardiol; 1998 Feb; 28(2):168-77. PubMed ID: 9534058 [TBL] [Abstract][Full Text] [Related]
17. [Cholesterol: blood levels or total risk as a guide to preventive treatment?]. Mathes P Z Kardiol; 2004; 93 Suppl 2():II16-20. PubMed ID: 15021991 [TBL] [Abstract][Full Text] [Related]
18. Management of hypercholesterolaemia in the patient with diabetes. Packard C; Olsson AG Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606 [TBL] [Abstract][Full Text] [Related]